Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare aspirin + clopidogrel with aspirin alone as
antithrombotic treatment following transcatheter aortic valve implantation (TAVI) for the
prevention of major ischemic events [myocardial infarction (MI), ischemic stroke] or death
without increasing the risk of major bleeding events.
Phase:
Phase 4
Details
Lead Sponsor:
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec